Total Payments
$14,414
2022 Payments
$42.31
Companies
10
Transactions
83
Medicare Patients
724
Medicare Billing
$724,058
Payment Breakdown by Category
Consulting$11,250 (78.0%)
Food & Beverage$2,586 (17.9%)
Travel$578.25 (4.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,250 | 9 | 78.0% |
| Food and Beverage | $2,586 | 63 | 17.9% |
| Travel and Lodging | $578.25 | 11 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Orexo US, Inc. | $13,143 | 43 | $0 (2020) |
| US WorldMeds, LLC | $445.40 | 11 | $0 (2019) |
| PFIZER INC. | $224.48 | 9 | $0 (2017) |
| Alkermes, Inc. | $168.59 | 4 | $0 (2019) |
| BioDelivery Sciences International, Inc. | $145.12 | 6 | $0 (2018) |
| Indivior Inc. | $120.52 | 1 | $0 (2018) |
| Purdue Pharma L.P. | $89.25 | 5 | $0 (2017) |
| PAINTEQ LLC | $42.31 | 1 | $0 (2022) |
| Depomed, Inc. | $25.56 | 2 | $0 (2017) |
| Pernix Therapeutics Holdings, Inc. | $10.51 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $42.31 | 1 | PAINTEQ LLC ($42.31) |
| 2020 | $81.73 | 3 | Orexo US, Inc. ($81.73) |
| 2019 | $6,058 | 23 | Orexo US, Inc. ($5,770) |
| 2018 | $4,772 | 24 | Orexo US, Inc. ($4,310) |
| 2017 | $3,461 | 32 | Orexo US, Inc. ($2,980) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/06/2022 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $42.31 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/13/2020 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $51.39 | General |
| Category: Addiction Medicine | ||||||
| 05/13/2020 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $16.18 | General |
| Category: Addiction Medicine | ||||||
| 01/09/2020 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Addiction Medicine | ||||||
| 10/23/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $11.39 | General |
| Category: Addiction Medicine | ||||||
| 10/09/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/09/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $4.23 | General |
| Category: Addiction Medicine | ||||||
| 08/29/2019 | Orexo US, Inc. | Zubsolv (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: Addiction Medicine | ||||||
| 08/29/2019 | Orexo US, Inc. | Zubsolv (Drug) | Travel and Lodging | Cash or cash equivalent | $49.30 | General |
| Category: Addiction Medicine | ||||||
| 08/20/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $5.75 | General |
| Category: Addiction Medicine | ||||||
| 08/20/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $0.55 | General |
| Category: Addiction Medicine | ||||||
| 08/15/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $100.00 | General |
| Category: Addiction Medicine | ||||||
| 07/18/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Psychiatry/Psychology | ||||||
| 05/24/2019 | Orexo US, Inc. | Zubsolv (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: Addiction Medicine | ||||||
| 05/21/2019 | Orexo US, Inc. | Zubsolv (Drug) | Travel and Lodging | Cash or cash equivalent | $103.13 | General |
| Category: Addiction Medicine | ||||||
| 05/21/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $103.13 | General |
| Category: Addiction Medicine | ||||||
| 04/05/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $72.99 | General |
| Category: Addiction Medicine | ||||||
| 03/21/2019 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 01/28/2019 | Orexo US, Inc. | Zubsolv (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: Addiction Medicine | ||||||
| 01/28/2019 | Orexo US, Inc. | Zubsolv (Drug) | Travel and Lodging | Cash or cash equivalent | $58.58 | General |
| Category: Addiction Medicine | ||||||
| 01/24/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $121.79 | General |
| Category: Psychiatry/Psychology | ||||||
| 01/22/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $76.34 | General |
| Category: Addiction Medicine | ||||||
| 01/15/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $64.32 | General |
| Category: Addiction Medicine | ||||||
| 01/14/2019 | Orexo US, Inc. | Zubsolv (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: Addiction Medicine | ||||||
| 01/14/2019 | Orexo US, Inc. | Zubsolv (Drug) | Travel and Lodging | Cash or cash equivalent | $58.58 | General |
| Category: Addiction Medicine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 356 | 2,614 | $471,817 | $311,139 |
| 2020 | 5 | 368 | 3,889 | $646,143 | $412,919 |
Total Patients
724
Total Services
6,503
Medicare Billing
$724,058
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 107 | 941 | $281,700 | $186,764 | 66.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 119 | 1,213 | $108,990 | $75,363 | 69.1% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 86 | 247 | $61,750 | $38,678 | 62.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 107 | $10,197 | $5,505 | 54.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 22 | 106 | $9,180 | $4,830 | 52.6% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 158 | 1,859 | $464,750 | $289,123 | 62.2% |
| 80307 | Testing for presence of drug | Office | 2020 | 158 | 1,934 | $173,640 | $119,340 | 68.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 43 | $4,257 | $2,145 | 50.4% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 17 | 30 | $2,760 | $1,622 | 58.8% |
| 82075 | Breath alcohol level | Office | 2020 | 15 | 23 | $736.00 | $689.40 | 93.7% |
About Dr. Robert Masone, MD
Dr. Robert Masone, MD is a Pain Medicine healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861472441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Masone, MD has received a total of $14,414 in payments from pharmaceutical and medical device companies, with $42.31 received in 2022. These payments were reported across 83 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($11,250).
As a Medicare-enrolled provider, Masone has provided services to 724 Medicare beneficiaries, totaling 6,503 services with total Medicare billing of $724,058. Data is available for 2 years (2020–2021), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Addiction Medicine, Addiction Medicine
- Location Columbus, OH
- Active Since 01/19/2006
- Last Updated 12/15/2021
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861472441
Products in Payments
- Zubsolv (Drug) $13,143
- Lucemyra/Lofexidine (Drug) $445.40
- CHANTIX (Drug) $160.01
- BUNAVAIL 2.1 mg 30-count box (Drug) $145.12
- VIVITROL (Drug) $125.00
- SUBLOCADE (Drug) $120.52
- OXYCONTIN (Drug) $57.58
- Vivitrol 380 mg (Drug) $43.59
- PAINTEQ (Device) $42.31
- LYRICA (Drug) $35.70
- FLECTOR PATCH (Drug) $28.77
- Nucynta (Drug) $25.56
- HYSINGLA ER (Drug) $12.11
- ZOHYDRO ER (Drug) $10.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Columbus
Gladstone Mcdowell, M.d, M.D
Pain Medicine — Payments: $657,056
Pain Medicine $657,056
Tristan Weaver, M.d, M.D
Pain Medicine — Payments: $203,310
Pain Medicine $203,310
David Walega, Md, MD
Pain Medicine — Payments: $90,946
Pain Medicine $90,946
Dr. Gary Dawson, Md, MD
Pain Medicine — Payments: $17,041
Pain Medicine $17,041
Steven Bhutra, M.d, M.D
Pain Medicine — Payments: $13,081
Pain Medicine $13,081
Dr. Marcus Parker, M.d, M.D
Pain Medicine — Payments: $7,872
Pain Medicine $7,872